tiprankstipranks
Aquestive Therapeutics, Inc. (AQST)
NASDAQ:AQST
US Market
AQST
Aquestive Therapeutics
RESEARCH TOOLSreports
Want to see AQST full AI Analyst Report?

Aquestive Therapeutics (AQST) Revenue

2,472 Followers
StatisticsMarket CapRevenue

Aquestive Therapeutics Revenue

Aquestive Therapeutics had a revenue of 14.45M in the quarter ending Mar 31, 2026, with 11.00%. This bring the company's revenue in the last twelve months to 50.27M, Decreased 12.85%. In the fiscal year ending Dec 31, 2025, Aquestive Therapeutics had annual revenue of 44.55M with -22.61% growth.
Revenue (ttm)
50.27M
Revenue Growth
-7.30%
P/S Ratio
11.65
Revenue/Employee
$313,697
Employees
142
Market Cap
$518.74M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
44.55M-13.02M-22.61%
Dec 31, 2024
57.56M6.98M+13.80%
Dec 31, 2023
50.58M2.90M+6.09%
Dec 31, 2022
47.68M-3.15M-6.20%
Dec 31, 2021
50.83M4.98M+10.87%
Dec 31, 2020
45.85M-6.76M-12.85%
Dec 31, 2019
52.61M-14.82M-21.98%
Dec 31, 2018
67.43M512.00K+0.77%
Dec 31, 2017
66.92M――